HIV and Solid Organ Transplantation: A 15‐Year Retrospective Audit at a Tertiary Australian Transplant Centre

2021 ◽  
Author(s):  
DWJ Griffin ◽  
S Kotecha ◽  
G Basu ◽  
P Gow ◽  
JSY Lau ◽  
...  
Keyword(s):  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Solid Organ ◽  
Transplant Centre ◽  
Retrospective Audit

The interactive effect of parent personality and medication knowledge on adherence in children awaiting solid organ transplantation.

2017 ◽  
Vol 36 (5) ◽  
pp. 445-448 ◽  
Author(s):  
Jennifer L. Lee ◽  
Cyd K. Eaton ◽  
Kristin Loiselle Rich ◽  
Bonney Reed-Knight ◽  
Rochelle S. Liverman ◽  
...  
Keyword(s):  
Organ Transplantation ◽  
Interactive Effect ◽  
Solid Organ Transplantation ◽  
Solid Organ ◽  
Medication Knowledge ◽  
Parent Personality

Cytomegalovirus Prophylaxis in Solid Organ Transplantation

2012 ◽  
Vol 19 (35) ◽  
pp. 5957-5963 ◽  
Author(s):  
S. P. Alexopoulos ◽  
L. Lindberg ◽  
R. K. Subramanyan ◽  
L. Matsuoka
Keyword(s):  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Solid Organ

Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions

2020 ◽  
Vol 26 (28) ◽  
pp. 3497-3506
Author(s):  
Raymund R. Razonable
Keyword(s):  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Organ Transplant ◽  
Solid Organ Transplant ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Cmv Infection ◽  
Future Directions ◽  
Prevention And Treatment ◽  
Solid Organ Transplant Recipients

Cytomegalovirus is the classic opportunistic infection after solid organ transplantation. This review will discuss updates and future directions in the diagnosis, prevention and treatment of CMV infection in solid organ transplant recipients. Antiviral prophylaxis and pre-emptive therapy are the mainstays of CMV prevention, but they should not be mutually exclusive and each strategy should be considered depending on a specific situation. The lack of a widely applicable viral load threshold for diagnosis and preemptive therapy is emphasized as a major factor that should pave the way for an individualized approach to prevention. Valganciclovir and intravenous ganciclovir remain as drugs of choice for CMV management, and strategies for managing drug-resistant CMV infection are enumerated. There is increasing use of CMV-specific cell-mediated immune assays to stratify the risk of CMV infection after solid organ transplantation, and their potential role in optimizing CMV prevention and treatment efforts is discussed.

scholarly journals Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0135807 ◽  
Author(s):  
Fabian Schnitzler ◽  
Matthias Friedrich ◽  
Johannes Stallhofer ◽  
Ulf Schönermarck ◽  
Michael Fischereder ◽  
...  
Keyword(s):  
Organ Transplantation ◽  
Inflammatory Bowel Diseases ◽  
Solid Organ Transplantation ◽  
Solid Organ ◽  
Single Center ◽  
Bowel Diseases ◽  
Inflammatory Bowel

scholarly journals COVID‐19 in solid organ transplantation: an analysis of the impact on transplant activity and wait lists

2020 ◽  
Vol 34 (1) ◽  
pp. 209-212
Author(s):  
Maria Irene Bellini ◽  
Francesco Tortorici ◽  
Marco Capogni
Keyword(s):  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Solid Organ ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document